Live News Reader

Some of the articles presented on this website are accessed through RSS feeds from third-party sources that are not necessarily part of the Histiocytosis Association. While we try to select appropriate feeds to prevent objectionable content from being displayed, the presence of any article does not indicate endorsement or recommendation by the Histiocytosis Association.

If you know of a histio-related article that isn't shown here, please send the article to outreach@histio.org.

"Erdheim-Chester disease" - Google News
Erdheim Chester Disease Treatment Market Global Industry Analysis Segments Top Key Players Drivers And Trends To 2026 | Bausch Health, Cadila Healthcare, SANIS, Aphena Pharma Solutions - PRnews Leader
Erdheim Chester Disease Treatment Market Global Industry Analysis Segments Top Key Players Drivers And Trends To 2026 | Bausch Health, Cadila Healthcare, SANIS, Aphena Pharma Solutions  PRnews Leader
Monday, October 19, 2020 3:02:38 PM

LocalLit book review: A firsthand account how a New Lenox man is beating his rare disease - The Herald-News
LocalLit book review: A firsthand account how a New Lenox man is beating his rare disease  The Herald-News
Thursday, October 15, 2020 3:00:00 AM

LocalLit spotlight: New Lenox man writes memoir about his rare diease - The Herald-News
LocalLit spotlight: New Lenox man writes memoir about his rare diease  The Herald-News
Sunday, October 11, 2020 3:00:00 AM

UAB joins the Erdheim-Chester Disease Care Center Network - UAB News
UAB joins the Erdheim-Chester Disease Care Center Network  UAB News
Tuesday, February 25, 2020 3:00:00 AM

Erdheim Chester Disease Treatment Market Size, Share, Scope, Growth, Demand and Future Potential of Industry 2027 - Stock Market Vista
Erdheim Chester Disease Treatment Market Size, Share, Scope, Growth, Demand and Future Potential of Industry 2027  Stock Market Vista
Monday, October 19, 2020 10:01:13 PM

FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer - FDA.gov
FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer  FDA.gov
Monday, November 6, 2017 3:00:00 AM

Largest Study of Its Kind Reveals New Targetable Genetic Causes of the Rare Blood Disorder Histiocytosis - On Cancer - Memorial Sloan Kettering
Largest Study of Its Kind Reveals New Targetable Genetic Causes of the Rare Blood Disorder Histiocytosis  On Cancer - Memorial Sloan Kettering
Wednesday, December 4, 2019 3:00:00 AM

FDA Approves Vemurafenib for Treating Erdheim-Chester Disease - Cancer Network
FDA Approves Vemurafenib for Treating Erdheim-Chester Disease  Cancer Network
Thursday, November 9, 2017 3:00:00 AM

The ultra-rare Erdheim-Chester disease: Turning grief into a campaign for a cure - Washington Post
The ultra-rare Erdheim-Chester disease: Turning grief into a campaign for a cure  Washington Post
Monday, November 17, 2014 3:00:00 AM

Genes associated with Erdheim-Chester disease also linked to cancer - Medical Xpress
Genes associated with Erdheim-Chester disease also linked to cancer  Medical Xpress
Friday, March 31, 2017 3:00:00 AM

Share with Others

© Histiocytosis Association, Inc.
332 North Broadway, Pitman, New Jersey  08071 USA
Phone: +1 856-589-6606 | Fax: +1 856-589-6614
| info@histio.org
US & Canada Toll-Free: 1-800-548-2758 
Privacy | DisclaimerState Fundraising Notices 
Tax ID: 22-2827069 | Contact Us 
Instagram   


¿No Habla Inglés? Si usted puede escribirme sus preguntas y preocupaciones a la dirección de correo electrónico: outreach@histio.org. Nosotros podremos responderle tan pronto nos sea possible. Gracias!